Business

1 thru 10 of 8703 Stories

The Issue: Minimum Wage. The Candidates? Not Exactly Crystal Clear

FINANCE | By Christopher S. Rugaber | Sep 25
Raising the federal minimum wage from $7.25 an hour to $12 would lift pay for 1 in 4 employees nationwide, according to the liberal Economic Policy Institute. But it would also boost costs for employers and may slow hiring.

Samsung Suffers Backlash in China Over Smartphone Response

CORPORATE | By Joe McDonald | Sep 25
Potential damage to its image threatens to disrupt Samsung's efforts to use the Note 7 to propel faster growth in a crowded Chinese market where it has slipped to sixth place.

New Black Museum Prepared to Deal with Visitors' Emotions

CORPORATE | By Jesse J. Holland | Sep 24
America's newest museum brings to life all the pain and tribulations of the black experience and its creators expect many visitors will be shaken by what they see and hear.

Report: Staff Shortages Hamper U.S. Wildlife Refuges

CORPORATE | By Gillian Flaccus | Sep 24
Staffing at the nation's 565 wildlife refuges and related properties shrank nearly 15 percent in the past decade, and more than one-third of those locations don't have any staff on site.

Marriott Buys Starwood, Becoming World's Largest Hotel Chain

CORPORATE | By Scott Mayerwitz | Sep 23
Several of the best-known names in travel are now united in one hotel company.

1,400 Investor Lawsuits Seek 8.2 Billion Euros from VW

LEGAL | Sep 23
A German court says it has added staff and storage space to handle a flood of 1,400 investor lawsuits against Volkswagen seeking damages worth 8.2 billion euros ($9.2 billion).

Chipotle Makes New Push to Convince People Its Food Is Safe

CORPORATE | By Candice Choi | Sep 23
Chipotle is making another push to convince people that its food won't make them sick, with plans to run more newspaper and digital ads outlining the safety steps it has taken since last year's E. coli outbreak.

Mylan CEO Defends EpiPen Prices

CORPORATE | By Mary Clare Jalonick | Sep 23
The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens and is signaling the company has no plans to lower prices despite a public outcry.

Treat Your Marriage Like a Business

FINANCE | By Liz Weston, NerdWallet Columnist | Sep 22
My artist husband likes to say that if I were in charge of our spending, we'd be sitting on milk crates instead of furniture and that if he were in charge, we'd have no retirement accounts.

Banks Focus More on New Accounts -- and the Fees They Bring

FINANCE | By Ken Sweet | Sep 22
When Wells Fargo CEO John Stumpf testifies before a Senate committee hearing Tuesday, it won't be just his bank under fire for turning friendly branches into high-pressure sales centers. It'll be the entire industry.

1 thru 10 of 8703 Stories